Journal Mobile Options
Table of Contents
Vol. 45, No. 2, 1999
Issue release date: March–April 1999

Differential Effects of Pharmacological Doses of Melatonin on Malondialdehyde and Glutathione Levels in Young and Old Rats

Akbulut K.G. · Gönül B. · Akbulut H.
To view the fulltext, log in and/or choose pay-per-view option

Individual Users: Register with Karger Login Information

Please create your User ID & Password





Contact Information











I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

Abstract

Background: The free radical theory of aging suggests the oxygen-derived species as the causative agents and free radical scavengers as the defense systems in aging process. The exact role of the free radical scavenging effects of melatonin in aging remains to be clarified. Objective: In this experimental study, we investigated the age-related changes of malondialdehyde (MDA), a lipid peroxidation product, and glutathione (GSH) and the effects of exogenous melatonin. Methods: Plasma, liver, and lung MDA and GSH levels of 9- and 28-month-old rats were measured. Results: Plasma, lung, and liver MDA levels of old rats were significantly higher than those of the young ones (p = 0.024, p = 0.005, and p = 0.0007, respectively). However, while the lung GSH levels were found to be significantly decreased in the control group of old rats as compared with young ones (p = 0.005), the liver GSH levels were unchanged. Plasma MDA levels were found to be significantly lower in the melatonin group of old rats as compared with the control group (p = 0.020) but lung and liver MDA levels were not significantly different. There were no significant differences in the levels of measured parameters between both groups of young rats. Conclusion: Our results suggest that increased levels of lipid peroxidation products may have a role in aging, and exogenous melatonin may delay the aging process of tissues by means of its free radical scavenging effects.



Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

References

  1. Harman D: Free radical theory of aging. Mutat Res 1992;275:257–266.
  2. Freeman BA, Crapo JD: Free radicals and tissue injury. Lab Invest 1982;47:412–426.
  3. Esterbauer H, Cheeseman KH: Determination of aldehydic lipid peroxidation products: Malonaldehyde and 4-hydroxynonenal. Methods Enzymol 1990;186:407–421.
  4. Akbulut H, Akbulut KG, Gönül B: Malondialdehyde and glutathione in rat gastric mucosa and effects of exogenous melatonin. Dig Dis Sci 1997;42:1381–1382.

    External Resources

  5. Uysal M, Seçkin S, Koçak-Toker N, Öz H: Increased hepatic lipid peroxidation in aged mice. Mech Ageing Dev 1989;48:85–89.
  6. Perez R, López M, Barja De Quiroga G: Aging and lung antioxidant enzymes: Glutathione and lipid peroxidation in the rat. Free Radic Biol Med 1991;10:35–39.
  7. Matsuo M, Gami F, Dooley MM: Age-related alterations in antioxidant capacity and lipid peroxidation in brain, liver, and lung homogenates of normal and vitamin-E-deficient rats. Mechan Ageing Dev 1992;64:273–292.
  8. Yen TC, King KL, Lee HC, Yeh SH, Wei YH: Age-dependent increase of mitochondrial DNA deletions together with lipid peroxides and superoxide dismutase in human liver mitochondria. Free Radic Biol Med 1994;16:207–214.
  9. Teromoto S, Fukuchi Y, Uejima Y, Teromoto K, Orimo H: Biochemical characteristics of lungs in senescence-accelerated mouse (SAM). Eur Respir J 1995;8:450–456.
  10. Barja de Quiroga G, Perz-Campo R, López Torves M: Anti-oxidant defences and peroxidation in liver and brain of aged rats. Biochem J 1990;272:247–250.
  11. Teromoto S, Fukuchi Y, Uejima Y, Teromoto K, Itoh H, Osimo H: Age-related changes in the antixoxidant screen of the distal lung in mice. Lung 1994;172:223–230.
  12. Stio M, Iantomasi T, Favilli F, Marracchini P, Lunghi B, Vincenzini MT,Treves C: Glutathione metabolism in heart and liver of the aging rat. Biochem Cell Biol 1994;72:58–61.
  13. Poeggeler B, Reiter FJ, Tan D-X, Chan L-D, Manchester LC: Melatonin, hydroxyl radical mediated oxidative damage and aging: A hypothesis. J Pineal Res 1993;14:151–168.
  14. Reiter RJ, Tan D, Poeggeler B, Menendez-Peleaz A, Chen L-D, Saarela S: Melatonin as a free radical scavenger: Implications for aging and age-related diseases. Ann NY Acad Sci 1994;719:1–12.
  15. Reiter RJ: Antioxidant actions of melatonin. Adv Pharmacol 1997;38:103–117.

    External Resources

  16. Humbert W, Pevet P: The decrease of pineal melatonin production with age: Causes and consequences. Ann NY Acad Sci 1994;719:43–63.
  17. Yagi K: Assay for serum lipid peroxide level and its clinical significance; in Yagi K (ed): Lipid Peroxides in Biology and Medicine. New York, Academic Press, 1982, pp 223–242.
  18. Casini A, Ferrali M, Pompella A, Maellaro E, Comborti M: Lipid peroxidation and cellular damage in extrahepatic tissue of bromobenzene intoxicated mice. Am J Pathol 1986;123:520–531.

    External Resources

  19. Aykaç G, Uysal M, Yalçın AS, Koçak-Toker N, Sivas A, Öz H: The effects of chronic ethanol ingestion on hepatic lipid peroxide, glutathione, glutathione peroxidase and glutathione transferase in rats. Toxicology 1985;36:71–76.
  20. Ceballos-Picot I, Nicole A, Clement M, Bourre JM, Sinet PM: Age-related changes in antioxidant enzymes and lipid peroxidation in brains of control and transgenic mice overexpressing copper-zinc superoxide dismutase. Mutat Res 1992;275:281–293.
  21. Flagg EW, Coates RJ, Jones DP, Eley JW, Gunter EW, Jackson B, Greenberg RS: Plasma total glutathione in humans and its association with demographic and health-related factors. Br J Nutr 1993;70:797–808.
  22. Zhang JR, Andrus PK, Hall ED: Age-related regional changes in hydroxyl radical stress and antioxidant in gerbil brain. J Neurochem 1993;61:1640–1647.
  23. Thomas DR, Miles A: Melatonin secretion and age. Biol Psychol 1989;25:365–367.
  24. Reiter RJ: The aging pineal gland and its physiological consequences. Bioessays 1992;14:169–175.
  25. Pierpaoli W, Dall’ara A, Pedrinis E, Regelson W: The pineal control of aging: The effects of melatonin and pineal grafting on the survival of older mice. Ann NY Acad Sci 1993;621:291–313.
  26. Reiter RJ, Poeggeler B, Tan DX, Chen L-D, Manchester LC, Guevero JM: Antioxidant capacity of melatonin: A novel action not requiring a receptor. Neuroendocrinol Lett 1993;15:103–116.
  27. Melchiorri D, Reiter RJ, Attia AM, Hara M, Burgos A, Nistico G: Potent protective effects of melatonin on in vivo paraquat induced oxidative damage in rats. Life Sci 1994;56:83–89.
  28. Sewerynek E, Melchiorri D, Chen L, Reiter RJ: Melatonin reduces both basal and bacterial lipopolysaccaride-induced lipid peroxidation in vitro. Free Radic Biol Med 1995;19:903–909.

    External Resources

  29. Pierrefiche G, Laborit H: Oxygen radicals, melatonin, and aging. Exp Gerontol 1995;30:213–227.

    External Resources

  30. Pablos MI, Reiter RJ, Chavary JI, Ortiz GG, Guerrero JM, Sewerynek E, Agapito MT, Melchiorri D, Lawrence R, Deneke SM: Acutely administered melatonin reduces oxidative damage in lung and brain induced by hyperbaric oxygen. J Appl Physiol 1997;83:354–358.
  31. Nair NPV, Hariharasubramanian N, Pilapil C, Haac I, Thavundayil JX: Plasma melatonin – an index of brain aging in humans. Biol Psychiatry 1986;21:141–150.
  32. Reiter RJ, Richardson BA, Johnson LY, Ferguson BN, Dish OT: Pineal melatonin rhythm: Reduction in aging Syrian hamsters. Science 1990;210:1372–1373.


Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50